This article is not complete. In order for a drug to be approved by the FDA for a particular condition, it must demonstrate (through expensive clinical trials) superior efficacy to existing treatments unless the drug is considered a generic. It's hard to say if a drug with slight molecular modifications could be said to be a "generic" form of another. There's a good chance the answer would be no, because slight molecular modifications can cause significant differences in efficacy.